Subcutaneous interleukin-2 and interferon alfa administration in patients with metastatic renal cell carcinoma: final results of SCAPP III, a large, multicenter, phase II, nonrandomized study with sequential analysis design--the Subcutaneous Administration Propeukin Program Cooperative Group.
J Clin Oncol
; 21(21): 3987-94, 2003 Nov 01.
Article
em En
| MEDLINE
| ID: mdl-14581421
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Carcinoma de Células Renais
/
Interleucina-2
/
Interferon-alfa
/
Neoplasias Renais
/
Antineoplásicos
Idioma:
En
Ano de publicação:
2003
Tipo de documento:
Article